Anemia for the USMLE Step 1 Exam
Overview of Anemia
- Definition:
- Anemia is a condition marked by low hemoglobin (Hb) or hematocrit (Hct) levels, resulting in decreased oxygen-carrying capacity.
- Criteria for anemia:
- Men: Hb <13.5 g/dL or Hct <41%
- Women: Hb <12 g/dL or Hct <36%
- Classification by RBC Size (MCV):
- Microcytic (MCV <80 fL): Often caused by iron deficiency, thalassemia, or anemia of chronic disease (ACD).
- Normocytic (MCV 80–100 fL): Seen in ACD, hemolytic anemia, or acute blood loss.
- Macrocytic (MCV >100 fL): Usually due to vitamin B12 or folate deficiency, alcohol use, or liver disease.
Microcytic Anemias
- Iron Deficiency Anemia:
- Etiology: Due to inadequate iron intake, malabsorption (e.g., celiac disease), or chronic blood loss.
- Pathophysiology: Iron deficiency leads to low hemoglobin synthesis and hypochromic, microcytic RBCs.
- Diagnosis: Low serum iron and ferritin, high total iron-binding capacity (TIBC).
- Treatment: Iron supplementation and addressing the underlying cause.
- Thalassemia:
- Etiology: Genetic disorder reducing synthesis of alpha or beta globin chains.
- Diagnosis: Microcytic anemia with normal iron levels; hemoglobin electrophoresis shows abnormal hemoglobin types.
- Treatment: Supportive care, blood transfusions if severe, and iron chelation for transfusion-related iron overload.
- Anemia of Chronic Disease (ACD):
- Etiology: Associated with chronic infections, cancer, autoimmune diseases.
- Pathophysiology: Inflammatory cytokines impair iron metabolism and RBC production.
- Diagnosis: Low serum iron and TIBC, normal or elevated ferritin.
- Treatment: Manage underlying disease; erythropoiesis-stimulating agents (ESAs) in specific cases.
Normocytic Anemias
- Hemolytic Anemia:
- Etiology: Includes hereditary (e.g., hereditary spherocytosis, G6PD deficiency) and acquired causes (e.g., autoimmune hemolysis).
- Diagnosis: Elevated reticulocyte count, increased indirect bilirubin, low haptoglobin.
- Treatment: Specific to cause; for autoimmune, corticosteroids or immunosuppressants may be required.
- Aplastic Anemia:
- Etiology: Caused by bone marrow failure due to autoimmune, viral, or drug-induced factors.
- Diagnosis: Pancytopenia with hypocellular bone marrow.
- Treatment: Immunosuppressive therapy or bone marrow transplant in severe cases.
Macrocytic Anemias
- Vitamin B12 Deficiency:
- Etiology: Malabsorption (e.g., pernicious anemia, gastric surgery) or dietary insufficiency.
- Pathophysiology: B12 is needed for DNA synthesis; deficiency causes ineffective erythropoiesis and macrocytosis.
- Diagnosis: Low serum B12, elevated methylmalonic acid (MMA) and homocysteine levels.
- Treatment: B12 supplementation (oral or parenteral).
- Folate Deficiency:
- Etiology: Common in alcoholism, malnutrition, and certain medications (e.g., methotrexate).
- Diagnosis: Low serum folate, elevated homocysteine, normal MMA.
- Treatment: Oral folate supplementation and dietary adjustments.
Diagnostic Workup
- Complete Blood Count (CBC):
- Provides hemoglobin, hematocrit, and MCV for classification.
- Iron Studies:
- Serum iron, ferritin, TIBC, and transferrin saturation help distinguish iron deficiency from ACD.
- Reticulocyte Count:
- Assesses bone marrow response; elevated in hemolytic anemias, decreased in production anemias.
- Peripheral Blood Smear:
- Identifies specific RBC morphologies (e.g., schistocytes in hemolysis, hypersegmented neutrophils in B12 deficiency).
Key Points
- Anemia is classified by RBC size (microcytic, normocytic, macrocytic) to guide diagnosis and treatment.
- Microcytic anemia causes include iron deficiency, thalassemia, and chronic disease, often requiring iron studies for diagnosis.
- Normocytic anemia can result from blood loss, hemolysis, or bone marrow disorders, with reticulocyte count aiding in differentiation.
- Macrocytic anemia commonly results from vitamin B12 or folate deficiency, with specific testing for MMA and homocysteine to confirm.
- Treatment varies based on etiology, with iron and vitamin supplementation for deficiencies, immunosuppressive therapy for aplastic anemia, and blood transfusions for severe cases.